Replidyne
Louisville
About Replidyne
Replidyne is a specialty pharmaceutical company focused on developing and commercializing innovative anti-infective products. The company is building its development pipeline based on both its proprietary DNA replication technology and in-licensing efforts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $13.0M
- Funding stage: M&A
- Last round: Series A (Apr 2002)
- Ticker: nasdaq:RDYN
- Website: replidyne.com
- Phone: 877.274.0901
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/replidyne-1065848 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.